135 related articles for article (PubMed ID: 16116651)
1. Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy.
Hinkle RT; Dolan E; Cody DB; Bauer MB; Isfort RJ
Muscle Nerve; 2005 Dec; 32(6):775-81. PubMed ID: 16116651
[TBL] [Abstract][Full Text] [Related]
2. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
Dodd SL; Koesterer TJ
Aviat Space Environ Med; 2002 Jul; 73(7):635-9. PubMed ID: 12137098
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
[TBL] [Abstract][Full Text] [Related]
4. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
Tatlicioğlu T
Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with PDE III inhibitor for heart failure].
Watanabe H; Kajimoto K; Kawana M
Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
[No Abstract] [Full Text] [Related]
7. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting.
Ryall JG; Lynch GS
Pharmacol Ther; 2008 Dec; 120(3):219-32. PubMed ID: 18834902
[TBL] [Abstract][Full Text] [Related]
8. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
Oger S; Behr-Roussel D; Gorny D; Denys P; Lebret T; Alexandre L; Giuliano F
Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2007 Mar; 559(2-3):219-26. PubMed ID: 17250824
[TBL] [Abstract][Full Text] [Related]
10. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphodiesterase-III inhibitors on sevoflurane-induced impairment of rat diaphragmatic function.
Uesugi T; Mikawa K; Nishina K; Kodama SI; Obara H
Acta Anaesthesiol Scand; 2005 Jul; 49(6):819-26. PubMed ID: 15954966
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.
Barreto EO; Carvalho VF; Lagente V; Lugnier C; Cordeiro RS; Martins MA; E Silva PM
Int Immunopharmacol; 2004 Jun; 4(6):755-62. PubMed ID: 15135317
[TBL] [Abstract][Full Text] [Related]
14. [Phosphodiesterase inhibition as a therapeutic principle].
Scholz H
Z Kardiol; 1994; 83 Suppl 2():1-5. PubMed ID: 8091820
[TBL] [Abstract][Full Text] [Related]
15. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4.
Brown DM; Hutchison L; Donaldson K; MacKenzie SJ; Dick CA; Stone V
Toxicol Lett; 2007 Jan; 168(1):1-6. PubMed ID: 17129690
[TBL] [Abstract][Full Text] [Related]
16. Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle.
Bloom TJ
Can J Physiol Pharmacol; 2005 Nov; 83(11):1055-60. PubMed ID: 16391714
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte am Esch J
Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo.
McCluskie K; Klein U; Linnevers C; Ji YH; Yang A; Husfeld C; Thomas GR
J Pharmacol Exp Ther; 2006 Oct; 319(1):468-76. PubMed ID: 16861399
[TBL] [Abstract][Full Text] [Related]
19. Denervation increases clenbuterol sensitivity in muscle from young rats.
Maltin CA; Delday MI; Hay SM; Baillie AG
Muscle Nerve; 1992 Feb; 15(2):188-92. PubMed ID: 1549139
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
